Works matching DE "JOHN Cunningham virus"
Results: 708
Brain biopsy in suspected non-neoplastic neurological disease.
- Published in:
- Acta Neurochirurgica, 2019, v. 161, n. 6, p. 1139, doi. 10.1007/s00701-019-03910-8
- By:
- Publication type:
- Article
Progressive multifocal leukoencephalopathy and spectrum of predisposing conditions: a 20-year retrospective cohort study in a tertiary center in São Paulo, Brazil.
- Published in:
- Neurological Sciences, 2025, v. 46, n. 1, p. 365, doi. 10.1007/s10072-024-07669-4
- By:
- Publication type:
- Article
Ocrelizumab use in multiple sclerosis: a real-world experience in a changing therapeutic scenario.
- Published in:
- Neurological Sciences, 2024, v. 45, n. 8, p. 3951, doi. 10.1007/s10072-024-07449-0
- By:
- Publication type:
- Article
A case of early disease rebound after fingolimod discontinuation in a patient with multiple sclerosis and SARS-CoV-2 infection.
- Published in:
- Neurological Sciences, 2024, v. 45, n. 6, p. 2423, doi. 10.1007/s10072-024-07490-z
- By:
- Publication type:
- Article
Progressive multifocal leukoencephalopathy in patients with chronic kidney disease.
- Published in:
- Neurological Sciences, 2024, v. 45, n. 4, p. 1619, doi. 10.1007/s10072-023-07182-0
- By:
- Publication type:
- Article
Isolated pontocerebellar leukoencephalopathy in HIV-related PML: focus on the "shrimp sign".
- Published in:
- Neurological Sciences, 2024, v. 45, n. 3, p. 1295, doi. 10.1007/s10072-023-07133-9
- By:
- Publication type:
- Article
Myelin oligodendrocyte glycoprotein antibody-associated disease preceding primary central nervous system lymphoma: causality or coincidence?
- Published in:
- Neurological Sciences, 2023, v. 44, n. 10, p. 3711, doi. 10.1007/s10072-023-06919-1
- By:
- Publication type:
- Article
Tofacitinib-induced progressive multifocal leukoencephalopathy–immune reconstitution inflammatory syndrome.
- Published in:
- Neurological Sciences, 2023, v. 44, n. 10, p. 3737, doi. 10.1007/s10072-023-06897-4
- By:
- Publication type:
- Article
Progressive multifocal leukoencephalopathy in multiple myeloma: a case report of a patient with SARS-CoV-2 infection and an updated systematic literature review.
- Published in:
- Neurological Sciences, 2023, v. 44, n. 9, p. 2995, doi. 10.1007/s10072-023-06944-0
- By:
- Publication type:
- Article
Viral pericarditis following ocrelizumab in a multiple sclerosis patient.
- Published in:
- Neurological Sciences, 2023, v. 44, n. 8, p. 2947, doi. 10.1007/s10072-023-06782-0
- By:
- Publication type:
- Article
On a 5-year-old girl with multiple sclerosis treated with natalizumab.
- Published in:
- Neurological Sciences, 2023, v. 44, n. 8, p. 2963, doi. 10.1007/s10072-023-06780-2
- By:
- Publication type:
- Article
Concomitant diagnosis of multiple sclerosis and human immunodeficiency virus (HIV) infection: case report and the review of literature.
- Published in:
- Neurological Sciences, 2023, v. 44, n. 7, p. 2305, doi. 10.1007/s10072-023-06727-7
- By:
- Publication type:
- Article
Progressive multifocal leukoencephalopathy or severe multiple sclerosis relapse following COVID-19 vaccine: a diagnostic challenge.
- Published in:
- Neurological Sciences, 2023, v. 44, n. 4, p. 1141, doi. 10.1007/s10072-023-06609-y
- By:
- Publication type:
- Article
Recurrent skin infections associated with natalizumab treatment.
- Published in:
- Neurological Sciences, 2023, v. 44, n. 3, p. 1093, doi. 10.1007/s10072-022-06481-2
- By:
- Publication type:
- Article
Long-term follow-up (up to 11 years) of an Italian pediatric MS cohort treated with Natalizumab: a multicenter, observational study.
- Published in:
- Neurological Sciences, 2022, v. 43, n. 11, p. 6415, doi. 10.1007/s10072-022-06211-8
- By:
- Publication type:
- Article
Frequency and clinical correlates of anti-nerve antibodies in a large population of CIDP patients included in the Italian database.
- Published in:
- Neurological Sciences, 2022, v. 43, n. 6, p. 3939, doi. 10.1007/s10072-021-05811-0
- By:
- Publication type:
- Article
Long-term comparative analysis of no evidence of disease activity (NEDA-3) status between multiple sclerosis patients treated with natalizumab and fingolimod for up to 4 years.
- Published in:
- Neurological Sciences, 2021, v. 42, n. 11, p. 4647, doi. 10.1007/s10072-021-05127-z
- By:
- Publication type:
- Article
Hereditary diffuse leukoencephalopathy with spheroids mimicking primary progressive aphasia: report of a Greek case.
- Published in:
- Neurological Sciences, 2021, v. 42, n. 8, p. 3431, doi. 10.1007/s10072-021-05257-4
- By:
- Publication type:
- Article
The impact of lymphocytosis and CD4/CD8 ratio on the anti-JCV antibody index and clinical data in patients treated with natalizumab.
- Published in:
- Neurological Sciences, 2021, v. 42, n. 7, p. 2847, doi. 10.1007/s10072-020-04897-2
- By:
- Publication type:
- Article
Clinical and magnetic resonance imaging monitoring in progressive multifocal leukoencephalopathy treated with pembrolizumab: a case report.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
Effectiveness of fingolimod in real-world relapsing-remitting multiple sclerosis Italian patients: the GENIUS study.
- Published in:
- Neurological Sciences, 2020, v. 41, n. 10, p. 2843, doi. 10.1007/s10072-020-04380-y
- By:
- Publication type:
- Article
Four cases of natalizumab-related PML: a less severe course in extended interval dosing?
- Published in:
- 2019
- By:
- Publication type:
- journal article
Holmes tremor caused by a natalizumab-related progressive multifocal leukoencephalopathy: a case report and brief review of the literature.
- Published in:
- 2019
- By:
- Publication type:
- Case Study
Neurological Disease-Affected Patients, including Multiple Sclerosis, Are Poor Responders to BKPyV, a Human Polyomavirus.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Analysis of potentially modifiable risk factors of multiple sclerosis.
- Published in:
- Current Neurology / Aktualno?ci Neurologiczne, 2024, v. 24, n. 2, p. 59, doi. 10.15557/AN.2024.0009
- By:
- Publication type:
- Article
Wpływ leczenia natalizumabem podczas ciąży na wyniki u dziecka.
- Published in:
- Current Neurology / Aktualno?ci Neurologiczne, 2022, v. 22, n. 4, p. 202, doi. 10.15557/AN.2022.0025
- By:
- Publication type:
- Article
Pierwsze polskie doświadczenia ze stosowaniem natalizumabu s.c.
- Published in:
- Current Neurology / Aktualno?ci Neurologiczne, 2022, v. 22, n. 4, p. 192, doi. 10.15557/AN.2022.0024
- By:
- Publication type:
- Article
Wpływ leczenia natalizumabem podczas ciąży na wyniki u dziecka.
- Published in:
- Current Neurology / Aktualno?ci Neurologiczne, 2022, v. 22, n. 3, p. 202, doi. 10.15557/AN.2022.0025
- By:
- Publication type:
- Article
Pierwsze polskie doświadczenia ze stosowaniem natalizumabu s.c.
- Published in:
- Current Neurology / Aktualno?ci Neurologiczne, 2022, v. 22, n. 3, p. 192, doi. 10.15557/AN.2022.0024
- By:
- Publication type:
- Article
15 lat stosowania natalizumabu w terapii stwardnienia rozsianego - opis 15 przypadków klinicznych.
- Published in:
- Current Neurology / Aktualno?ci Neurologiczne, 2022, v. 22, n. 1, p. 39, doi. 10.15557/AN.2022.0006
- By:
- Publication type:
- Article
Leczenie stwardnienia rozsianego w dobie pandemii COVID-19.
- Published in:
- Current Neurology / Aktualno?ci Neurologiczne, 2021, v. 21, n. 3, p. 131, doi. 10.15557/AN.2021.0017
- By:
- Publication type:
- Article
Natalizumab Treatment for Relapsing Multiple Sclerosis Stabilises Normal-Appearing White Matter Microstructure: A One-Year Prospective Ultra-High-Field Quantitative Imaging Study.
- Published in:
- Brain Sciences (2076-3425), 2023, v. 13, n. 10, p. 1464, doi. 10.3390/brainsci13101464
- By:
- Publication type:
- Article
Safety of Fingolimod in Patients with Multiple Sclerosis Switched from Natalizumab: Results from TRANSITION―A 2-Year, Multicenter, Observational, Cohort Study.
- Published in:
- Brain Sciences (2076-3425), 2022, v. 12, n. 2, p. 215, doi. 10.3390/brainsci12020215
- By:
- Publication type:
- Article
Clinical Immunological Correlations in Patients with Multiple Sclerosis Treated with Natalizumab.
- Published in:
- Brain Sciences (2076-3425), 2020, v. 10, n. 11, p. 802, doi. 10.3390/brainsci10110802
- By:
- Publication type:
- Article
Anti-CD20 Agents for Multiple Sclerosis: Spotlight on Ocrelizumab and Ofatumumab.
- Published in:
- Brain Sciences (2076-3425), 2020, v. 10, n. 10, p. 758, doi. 10.3390/brainsci10100758
- By:
- Publication type:
- Article
Human Polyomavirus JCPyV and Its Role in Progressive Multifocal Leukoencephalopathy and Oncogenesis.
- Published in:
- Frontiers in Oncology, 2019, p. 1, doi. 10.3389/fonc.2019.00711
- By:
- Publication type:
- Article
B cells and progressive multifocal leukoencephalopathy: search for the missing link.
- Published in:
- Frontiers in Immunology, 2015, p. 1, doi. 10.3389/fimmu.2015.00241
- By:
- Publication type:
- Article
Neuro-Ophthalmic Manifestations of HIV Infection.
- Published in:
- Ocular Immunology & Inflammation, 2020, v. 28, n. 7, p. 1085, doi. 10.1080/09273948.2019.1704024
- By:
- Publication type:
- Article
JC polyomavirus reactivation is common following allogeneic stem cell transplantation and its preemptive detection may prevent lethal complications.
- Published in:
- Bone Marrow Transplantation, 2015, v. 50, n. 7, p. 984, doi. 10.1038/bmt.2015.68
- By:
- Publication type:
- Article
Complete Blood Count in Multiple Sclerosis.
- Published in:
- Cumhuriyet Medical Journal, 2024, v. 46, n. 1, p. 8, doi. 10.7197/cmj.1369992
- By:
- Publication type:
- Article
BK Virus in Kidney Transplantation.
- Published in:
- International Journal of Organ Transplantation Medicine, 2023, v. 14, n. 4, p. 58
- By:
- Publication type:
- Article
Progressive Multifocal Leukoencephalopathy after Three Consecutive Liver Transplantations.
- Published in:
- 2015
- By:
- Publication type:
- Case Study
Comparative Effectiveness and Cost-Effectiveness of Natalizumab and Fingolimod in Patients with Inadequate Response to Disease-Modifying Therapies in Relapsing-Remitting Multiple Sclerosis in the United Kingdom.
- Published in:
- PharmacoEconomics, 2022, v. 40, n. 3, p. 323, doi. 10.1007/s40273-021-01106-6
- By:
- Publication type:
- Article
An AQP-4-IgG-Positive Patient with Neuroimaging Findings Suggestive of Multiple Sclerosis.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
HIV ENCEPHALITIS ASSOCIATED WITH NEUROTOXOPLASMOSIS.
- Published in:
- Romanian Journal of Functional & Clinical, Macro & Microscopical Anatomy & of Anthropology / Revista Româna de Anatomie Functionala si Clinica, Macro si Microscopica si de Antropologie, 2020, v. 19, n. 2, p. 96
- By:
- Publication type:
- Article
Progressive Multifocal Leukoencephalopathy Risk Mitigation: A Focus on Approved Immunomodulatory Drugs for Multiple Sclerosis Treatment.
- Published in:
- Journal of King Abdulaziz University: Medical Sciences, 2020, v. 27, n. 2, p. 33, doi. 10.4197/Med.27-2-6
- By:
- Publication type:
- Article
Are the Polyomaviruses BK and JC Associated with Opportunistic Infections, Graft-versus-Host Disease, or Worse Outcomes in Adult Patients Receiving Their First Allogeneic Stem Cell Transplantation with Low-Dose Alemtuzumab?
- Published in:
- Acta Haematologica, 2017, v. 138, n. 1, p. 3, doi. 10.1159/000468972
- By:
- Publication type:
- Article
Reactivation of Multiple Infectious Pathogens after Hematopoietic Stem Cell Transplantation.
- Published in:
- 2017
- By:
- Publication type:
- Letter to the Editor
Exploring JC Polyomavirus Sequences and Human Gene Expression in Brain Tissue of Patients With Progressive Multifocal Leukoencephalopathy.
- Published in:
- Journal of Infectious Diseases, 2024, v. 230, n. 3, p. e732, doi. 10.1093/infdis/jiae066
- By:
- Publication type:
- Article
JC Polyomavirus Modifies the Expression of Human microRNAs in Progressive Multifocal Leukoencephalopathy Brain.
- Published in:
- Journal of Infectious Diseases, 2023, v. 228, n. 7, p. 829, doi. 10.1093/infdis/jiad083
- By:
- Publication type:
- Article